Catherine Pearce - 12 Jan 2022 Form 4/A - Amendment Insider Report for CinCor Pharma, Inc.

Role
Chief Operating Officer
Signature
/s/ Cathy Rude, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
12 Jan 2022
Net transactions value
$0
Form type
4/A - Amendment
Filing time
13 Jan 2022, 15:21:19 UTC
Date Of Original Report
10 Jan 2022
Previous filing
13 Jan 2022
Next filing
19 Jan 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CINC Restricted Stock Units Award $0 +26,471 $0.000000 26,471 12 Jan 2022 Common Stock 26,471 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock.
F2 This Form 4 amendment is being filed to correct the original Form 4 filed on January 10, 2022. The Transaction Date was stated incorrectly on the original Form 4.
F3 The RSUs vest in two equal annual installments beginning January 11, 2023, subject to the continued service by the Reporting Person to the Issuer as of the applicable vesting date.